testosterone undecanoate has been researched along with Metabolic Syndrome in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Bruno, BJ; Cellai, I; Chidambaram, N; Cipriani, S; Comeglio, P; Filippi, S; Galli, A; Guarnieri, G; Kim, K; Maggi, M; Maseroli, E; Mello, T; Morelli, A; Papangkorn, K; Patel, MV; Rastrelli, G; Sarchielli, E; Vangara, K; Vignozzi, L | 1 |
| Doros, G; Haider, A; Saad, F; Traish, AM | 1 |
| Aversa, A; Bruzziches, R; Francomano, D; Ilacqua, A; Lenzi, A | 1 |
| Morales, A | 1 |
| Doros, G; Hammerer, PG; Yassin, AA; Yassin, DJ | 1 |
| Albareda, M; Chillarón, JJ; Colom, C; Fernández-Miró, M; Flores Le-Roux, JA; Fontserè, S; Pedro-Botet, J; Vila, L | 1 |
| Borisov, VV; Kalinchenko, SIu; Novikova, MS | 1 |
| Gooren, LJ; Haider, A; Padungtod, P; Saad, F | 2 |
| Kalinchenko, SY; Tishova, Y | 1 |
| Aversa, A; Bruzziches, R; Francomano, D; Lenzi, A; Spera, G | 1 |
| Aversa, A; Bruzziches, R; Francomano, D; Isidori, AM; Lenzi, A; Rosano, G; Spera, G | 1 |
| Giltay, EJ; Gooren, LJ; Kalinchenko, SY; Mskhalaya, GJ; Saad, F; Tishova, YA | 1 |
| Escovar, P; Fraile, C; Garcia, JA; Sanchez, PE | 1 |
| Aversa, A; Bruzziches, R; Di Luigi, L; Fornari, R; Francomano, D; Greco, EA; Lenzi, A; Migliaccio, S | 1 |
| Karpishchenko, AI; Loran, OB; Mazurov, VI; Pecherskiĭ, AV; Pecherskiĭ, VI; Semiglazov, VF | 1 |
| Loran, OB; Mittenberg, AG; Pecherskiĭ, AV; Pecherskiĭ, VI; Semiglazov, VF; Vonskiĭ, MS | 1 |
| Aleman, A; Bosch, JL; Emmelot-Vonk, MH; Grobbee, DE; Lock, TM; Nakhai Pour, HR; van der Schouw, YT; Verhaar, HJ | 1 |
| Gooren, L; Haider, A; Saad, F; Yassin, A | 1 |
1 review(s) available for testosterone undecanoate and Metabolic Syndrome
| Article | Year |
|---|---|
[Metabolic syndrome and chronic disease of the kidneys: the role of age-related androgenic deficiency. New approaches to treatment (review)].
Topics: Age Factors; Androgens; Dyslipidemias; Humans; Hypertension; Hypolipidemic Agents; Insulin Resistance; Kidney Failure, Chronic; Lactones; Metabolic Syndrome; Orlistat; Progesterone-Binding Globulin; Testosterone; Tumor Necrosis Factor-alpha; Tunica Intima | 2008 |
8 trial(s) available for testosterone undecanoate and Metabolic Syndrome
| Article | Year |
|---|---|
Testosterone undecanoate improves lipid profile in patients with type 1 diabetes and hypogonadotrophic hypogonadism.
Topics: Adult; Diabetes Mellitus, Type 1; Female; Humans; Hypogonadism; Lipid Metabolism; Lipids; Male; Metabolic Syndrome; Middle Aged; Spain; Testosterone | 2016 |
Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome.
Topics: Administration, Oral; Body Composition; Humans; Hypogonadism; Injections, Intramuscular; Insurance, Pharmaceutical Services; Italy; Male; Metabolic Syndrome; Middle Aged; Penile Erection; Testosterone | 2010 |
Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study.
Topics: Androgens; Atherosclerosis; Blood Glucose; Blood Pressure; Body Composition; Cardiovascular Diseases; Double-Blind Method; Humans; Hypogonadism; Male; Metabolic Syndrome; Middle Aged; Risk Factors; Testosterone; Waist Circumference | 2010 |
Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study.
Topics: Adult; Aged; Body Mass Index; C-Reactive Protein; Humans; Hypogonadism; Inflammation; Insulin; Interleukin-10; Interleukin-6; Leptin; Lipids; Male; Metabolic Syndrome; Middle Aged; Testosterone; Tumor Necrosis Factor-alpha; Waist Circumference; Waist-Hip Ratio | 2010 |
Testosterone undecanoate improves erectile dysfunction in hypogonadal men with the metabolic syndrome refractory to treatment with phosphodiesterase type 5 inhibitors alone.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Hypogonadism; Male; Metabolic Syndrome; Middle Aged; Phosphodiesterase 5 Inhibitors; Testosterone | 2011 |
Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study.
Topics: Aged; Androgens; Bone Density; Femur; Humans; Hypogonadism; Male; Metabolic Syndrome; Middle Aged; Obesity; Spine; Testosterone | 2012 |
Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.
Topics: Activities of Daily Living; Aged; Aging; Blood Glucose; Body Composition; Bone Density; Cognition; Double-Blind Method; Humans; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Middle Aged; Muscle Strength; Quality of Life; Testosterone | 2008 |
Effects of testosterone gel followed by parenteral testosterone undecanoate on sexual dysfunction and on features of the metabolic syndrome.
Topics: Aged; Androgens; Humans; Male; Metabolic Syndrome; Middle Aged; Sexual Dysfunction, Physiological; Testosterone | 2008 |
10 other study(ies) available for testosterone undecanoate and Metabolic Syndrome
| Article | Year |
|---|---|
Treatment potential of LPCN 1144 on liver health and metabolic regulation in a non-genomic, high fat diet induced NASH rabbit model.
Topics: Androgens; Animals; Diet, High-Fat; Disease Models, Animal; Fibrosis; Inflammation; Male; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Prodrugs; Rabbits; Testosterone | 2021 |
Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study.
Topics: Adult; Aged; Androgens; Blood Glucose; Blood Pressure; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Fasting; Glycated Hemoglobin; Humans; Hypogonadism; Lipid Metabolism; Long-Term Care; Male; Metabolic Syndrome; Middle Aged; Obesity; Organ Size; Prostate; Registries; Testosterone; Treatment Outcome; Triglycerides | 2014 |
Effects of 5-year treatment with testosterone undecanoate on lower urinary tract symptoms in obese men with hypogonadism and metabolic syndrome.
Topics: Aged; Androgens; Humans; Hypogonadism; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Middle Aged; Obesity; Testosterone; Time Factors; Treatment Outcome | 2014 |
Editorial comment.
Topics: Androgens; Humans; Hypogonadism; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Obesity; Testosterone | 2014 |
Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
Topics: Aged; Androgens; Body Composition; Body Mass Index; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Erectile Dysfunction; Humans; Hypogonadism; Male; Metabolic Syndrome; Middle Aged; Obesity; Penile Erection; Prospective Studies; Quality of Life; Testosterone; Triglycerides; Waist Circumference | 2014 |
Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men.
Topics: Adult; Aged; C-Reactive Protein; Humans; Male; Metabolic Syndrome; Middle Aged; Prostate; Prostatic Diseases; Testosterone; Urinary Bladder; Urologic Diseases | 2009 |
Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate.
Topics: Adult; Aged; Aging; Androgens; Body Mass Index; C-Reactive Protein; Cohort Studies; Fatty Liver; Humans; Hypogonadism; Liver; Male; Metabolic Syndrome; Middle Aged; Testosterone | 2010 |
Breaking the vicious circle of obesity: the metabolic syndrome and low testosterone by administration of testosterone to a young man with morbid obesity.
Topics: Adult; Androgens; Humans; Male; Metabolic Syndrome; Obesity, Morbid; Testosterone; Waist Circumference; Weight Loss | 2009 |
[The influence of partial androgen deficiency of aging men (PADAM) on the impulse regime of incretion of several hormones and mitotic activity].
Topics: Adult; Aged; Aging; Androgens; Andropause; Follicle Stimulating Hormone; Growth Hormone; Humans; Insulin; Luteinizing Hormone; Male; Metabolic Syndrome; Middle Aged; Testosterone; Testosterone Congeners | 2006 |
[Testosterone's role in regulating expression of genes of several proliferation factors].
Topics: Actins; Aged; Aging; Androgens; Andropause; Blood Cells; Cell Proliferation; Epidermal Growth Factor; Gene Expression; Genes, bcl-2; Humans; Male; Metabolic Diseases; Metabolic Syndrome; Middle Aged; Receptor, Insulin; Receptors, Estrogen; Receptors, Fibroblast Growth Factor; Testosterone; Testosterone Congeners | 2006 |